Ovarian cancer: a molecule prolongs the survival of women with a genetic mutation
In women with ovarian cancer with a BRCA gene mutation, the molecule olaparib would prolong survival by more than a ...
Read moreTag: PARP inhibitor
BRCA-mutated ovarian cancer: interest of a PARP inhibitor on progression-free survival
A new treatment greatly improves the maintenance treatment of BRCA mutated ovarian cancer. A change of treatment is announced.Two-year maintenance ...
Read more
A new association announces a revolution in the treatment of ovarian cancer
In ovarian cancer, the combination of a PARP inhibitor and an inhibitor of BRDA4, a small regulatory molecule, is effective ...
Read more